Consecutive patients (n = 126) with chronically elevated ALT and NAFLD underwent STOP-BANG questionnaire to estimate OSA risk and ultrasonographic carotid assessment. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.